ABDALLAH ALABADLA REMEMBERS THE NIGHT HE thought he was going to die. The college student had fled his home in Gaza City for Khan Younis, a place he thought would be safer. But soon after arriving, he found the city emptied of critical medical supplies.
"I went to every pharmacy in the area where I was staying, desperately looking for insulin," he said in a phone interview from Cairo, where he evacuated in March. "I thought I was going to die because I didn't find it. I don't know how to describe it. It was a horrible moment."
Alabadla, 23, was in his final semester at Al-Aqsa University, where he studied English literature before the October 7 attacks on Israel by Hamas and subsequent Israeli invasion of Gaza. He also has Type 1 diabetes and relies on taking insulin daily to stay alive.
Before the launch of Israel's offensive seeking to release the Israeli hostages and destroy Hamas, United Nations bodies estimated that up to 71,000 Palestinians in Gaza were living with diabetes as of November 2023. It is not known now how many of them have since fled or been killed.
Insulin is one of the medicines in "acute shortage" in Gaza, according to the World Health Organization, recalling a time before the advent of insulin therapy, when having diabetes-today considered a treatable condition-almost always meant a death sentence within a matter of days or weeks.
Alabadla and others say they have gone to extreme measures to survive the shortage. They now frequently switch between multiple types of insulin based on availability rather than what is recommended for their unique needs, use expired insulin or resort to insulin rationing-a potentially fatal practice.
Dr. Waseem Alzaanin is a physician in Deir al-Balah, in central Gaza. Like Alabadla, he has Type 1 diabetes.
Denne historien er fra August 02 - 09, 2024 (Double Issue)-utgaven av Newsweek Europe.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra August 02 - 09, 2024 (Double Issue)-utgaven av Newsweek Europe.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
A Mammoth Breakthrough
A biotech team has created a “woolly mouse,” marking a step forward in the quest to revive the long-extinct species
Ultra-Precision Manufacturing for Tomorrow's Batteries
When it comes to batteries, HYTC have emerged as the first-choice battery manufacturing partner in everything from personal electronics to electric vehicles.
Windward Roads Infrastructure: Paving Sint Maarten's Future with Innovation & Resilience
Building Resilience and Innovation in Caribbean Infrastructure
Flowone Leads in Bellows Seal Valves
Flowone is looking to international markets to continue its expansion, bringing advanced valves and precision engineering at remarkably competitive prices.
War of Words
JD Vance took Europe by surprise when he deemed a \"retreat\" of free speech one of the biggest threats to the continent. Newsweek explores freedom of expression there and in the U.S.
FOR Duty, FOR Love
At an age when many people would be retired, QUEEN CAMILLA is still focused on her royal responsibilities. Newsweek goes behind the scenes to examine her work and its impact
Not Just for the Taste of It
How Diet Coke, once a favorite of “It” girls, has become the new symbol of masculinity
Dylan Mulvaney
WHEN SOCIAL MEDIA INFLUENCER DYLAN MULVANEY, FAMOUS FOR CHRONIcling her gender transition online in \"365 Days of Girlhood,\" posted a sponsored video promoting Bud Light, it quickly went viral, but not necessarily in a good way.
From Shadows to Sight
A revolutionary gene therapy has given blind children with a rare eye disorder the ability to see
Building the Future: How FT Develepment is redefining Sint Maarten
In Sint Maarten, where turquoise waters meet golden sands, a quiet transformation is reshaping the island's future. Frank and Alexia Teboul, founders and directors of FT Development, are leading this change, blending resilience, ambition, and innovation. For investors, their work—and the island they call home—offers an invitation to imagine the possibilities.
